AbbVie's develops products in several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women’s health, as well as through its Allergan Aesthetics portfolio
Allergan is a part of AbbVie, marketing a portfolio of products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology.
Allergan is a leader in the migraine space, marketing BOTOX® (onabotulinumtoxinA) the first FDA-approved, preventive treatment for adult Chronic Migraine patients.